Pulmonx Chartis Tablet Console
K-Number: K180011 · 2018-07-13
ApplicantPulmonx Corporation
Decision Date2018-07-13
Product CodeBZG
Advisory CommitteeAN
DecisionSubstantially Equivalent
Device Summary
Pulmonx Chartis Tablet Console is a medical device manufactured by Pulmonx Corporation. It received FDA 510(k) clearance on 2018-07-13 under approval number K180011. The device is classified under product code BZG. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Pulmonx Chartis Tablet Console?
Pulmonx Chartis Tablet Console is a medical device that received FDA 510(k) clearance on 2018-07-13. It is manufactured by Pulmonx Corporation. The 510(k) number is K180011.
When was Pulmonx Chartis Tablet Console approved by the FDA?
Pulmonx Chartis Tablet Console received FDA 510(k) clearance on 2018-07-13, under approval number K180011.
What company makes Pulmonx Chartis Tablet Console?
Pulmonx Chartis Tablet Console is manufactured by Pulmonx Corporation.
What is the FDA product code for Pulmonx Chartis Tablet Console?
The FDA product code for Pulmonx Chartis Tablet Console is BZG.
Other Devices by Pulmonx Corporation
Related Devices (Code: BZG)
K161676Q13 SPIROLYSER®Fim Medical
K160116SpiroScoutGanshorn Medizin Electronic GmbH
K160253Vitalograph Model 6300 microVitalograph (Ireland) , Ltd.
K150515IQSense Flow Sensor MouthpieceSdi Diagnostics, Inc.
K163249GoSpiroMonitored Therapeutics, Inc.
K161536EasyOne Air SpirometerNdd Medizintechnik AG
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.